Ishita Drugs & Industries MD, chairman, board of directors and AGM
BSE: 524400Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹72.75.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹21 Cr4,064th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 8 Aug 2026
- 29.6
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 30 May 2026
- 1.8
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 8 Aug 2026
- 6.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 8 Aug 2026
- 5.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 30 May 2026
- 0.01
- Volume, BSEVolume. Shares traded on the last trading day.
- 211
Statutory auditor
Named in the results for the quarter to Mar 2026.
- M/s. Jaymin Shah & AssociatesPeer-review certificate valid to May 2027
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Ishita Drugs & Industries AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Ishita Drugs & Industries share news and announcements
Annual general meeting, 30 Sep 2026
5,165 shareholders on the register on 23 Sep 2026; present: 12 promoters and 20 others; votes counted by MEENU MAHESHWARI / MEENU MAHESHWARI AND ASSOCIATES.The company's voting result (opens in a new tab)
- To receive and adopt the audited accounts of the Company for the year ended 31st March 2026 along with report of auditors and directors thereon.Ordinary100.00% for0.00% against
Against: promoters 0.00% · other public 0.00%
Turnout: all 100.00% · promoters 100.00% · other public 100.00%
- To consider the re-appointment of M/s Jaymin Shah & Associates, Chartered Accountants (FRN No.129406W) as the Statutory Auditors of the Company for a period of one yearOrdinary100.00% for0.00% against
Against: promoters 0.00% · other public 0.00%
Turnout: all 100.00% · promoters 100.00% · other public 100.00%
To approve re-appointment of Mrs. Abha Agrawal (DIN: 01589479) as a Non-Executive Non-Independent Director of the Company post attaining the age of 75 years, and who retires by rotation, being eligible offers herself for re-appointment.MoreLess
SpecialPromoters have an interest in it86.92% for13.08% againstAgainst: promoters 0.00% · other public 42.38%
Turnout: all 53.80% · promoters 44.60% · other public 100.00%
- To approve the Related party transactions with Ishita PharmaceuticalsOrdinaryPromoters have an interest in it57.62% for42.38% against
Against: promoters 0.00% · other public 42.38%
Turnout: all 16.61% · promoters 0.00% · other public 100.00%
- To approve the Related party transactions with Anvi Lifesciences Private LimitedOrdinaryPromoters have an interest in it99.99% for0.01% against
Against: promoters 0.00% · other public 0.01%
Turnout: all 10.29% · promoters 0.00% · other public 100.00%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.